Warm welcome and congratulations to CancerX’s inaugural steering committee, which provides an additional layer of governance within our public-private partnership model. – CancerX Moonshot
Quoting CancerX Moonshot on LinkedIn:
“Warm welcome and congratulations to CancerX’s inaugural steering committee, which provides an additional layer of governance within our public-private partnership model:
▪️ David Fredrickson, Executive Vice President, Oncology Business, AstraZeneca
▪️ Rasu Shrestha, Chief Innovation and Commercialization Officer, Atrium Health
▪️ Ben Moscovitch, Healthcare and Life Science Public Policy Lead, Americas, Amazon Web Services (AWS)
▪️ Sally Werner, Chief Experience Officer, Cancer Support Community
▪️ Mary Tolikas, Senior Vice President and Chief Innovation Officer, Dana-Farber Cancer Institute
▪️ Omid Toloui, Vice President, Innovation, Elevance Health
▪️ Ted Gaubert, Chief Technology Officer, Graphite Health
▪️ Najat Khan, Chief Data Science Officer and Global Head, Strategy, Portfolio & Operations, R&D, The Janssen Pharmaceutical Companies of Johnson & Johnson
▪️ Andrea Downing, Chief Executive Officer, The Light Collective
▪️ Cait Brumme, Chief Exexutive Officer, MassChallenge
▪️ Kate Wallis, Vice President of Clinical Innovation, Point32Health
▪️ Matt Bettonville, Investor, Yosemite
This new group – in addition to the leadership and experience of our 125+ member organizations – positions us to execute CancerX’s priorities and activities within an ambitious timeframe – because cancer waits for no one.”
For details click here.
Source: CancerX Moonshot/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023